Drugmaker | featured news

Drugmakers script social media to push meds

It wasn't what you would call a casual get-together.  A popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse extol the virtues of Mirena, a birth control device sold by Bayer Healthcare.  The nurse was on Bayer's payroll.

 

J&J AIDS drug shows promise

J&J AIDS drug shows promise

Two pivotal trials of a Johnson & Johnson experimental HIV drug found it worked as well as an existing drug, with fewer side effects but also with nearly twice as many patients failing to respond to treatment.

 

Pfizer to cut 6,000 jobs, close more plants

Drugmaker Pfizer will cut 6,000, or 18 percent, of jobs at its 78 manufacturing plants over the next five years as it consolidates operations after  last year's purchase of  Wyeth.

 

In Health Reform, Boons for Hospitals and Drug Makers

With an overhaul, Congress would be giving the health care industry millions of customers in the next few years.

 

Drugmakers, FDA move to curb painkiller abuse

Drugmakers, FDA move to curb painkiller abuse

Pharmaceutical executives laid out plans Friday to prevent the misuse of prescription painkillers, under pressure from regulators trying to stop hundreds of fatal overdoses each year....

 

Cost-cutting drives Pfizer profit

Cost-cutting at drug maker Pfizer helps it to increase third-quarter profits despite falling sales of its medicines.

 

US and Canada regulators approve Pfizer-Wyeth deal (AP)

Pfizer Inc.'s $68 billion purchase of Wyeth will close Thursday after antitrust regulators in the U.S. and Canada cleared the deal, which will make Pfizer the world's largest drugmaker by revenue.

 

Johnson & Johnson buys 18 percent stake in Crucell

Health care giant Johnson & Johnson is jumping into the increasingly hot vaccine business by taking an 18 percent stake in Dutch biotechnology company Crucell NV and focusing more on preventive medicine....

 

Solvay sells drugs unit to Abbott for $6.6 billion

Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.61 billion) in cash and reinvest in chemicals and plastics.

 

Drugmaker Starts Testing Swine Flu Vaccine on Humans

Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said Wednesday.

 

Subscribe to this RSS topic: Syndicate content